Evidence map›Paper›PMID 35971625›Full record

ReviewBrain and behavior2022

A review of stem cell therapy: An emerging treatment for dementia in Alzheimer's and Parkinson's disease.

Aishwarya Umesh Pradhan, Olivier Uwishema, Helen Onyeaka, Irem Adanur, Burhan Dost

Open access · goldAbstract readReview
In one paragraph

Review in Brain and behavior, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Measles outbreak in Zimbabwe: An urgent rising concern.Annals of medicine and surgery (2012) · 2022
    Article
  14. Article
  15. Yellow fever outbreak in Kenya: A review.Annals of medicine and surgery (2012) · 2022
    Review
  16. Polio returns to the USA: An epidemiological alert.Annals of medicine and surgery (2012) · 2022
    Article
  17. Hepatitis A virus outbreak in Lebanon: Is it a matter of concern?Annals of medicine and surgery (2012) · 2022
    Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 4 countries.

Aishwarya Umesh PradhanOli Health Magazine Organization, Research and Education, Kigali, Rwanda.
Olivier UwishemaOli Health Magazine Organization, Research and Education, Kigali, Rwanda.ORCID 0000-0002-0692-9027
Helen OnyeakaSchool of Chemical Engineering, University of Birmingham, Edgbaston, Birmingham, UK.
Irem AdanurOli Health Magazine Organization, Research and Education, Kigali, Rwanda.
Burhan DostDepartment of Anesthesiology, School of Medicine, Ondokuz Mayis University, Kurupelit, Samsun, Turkey.
Karadeniz Technical University · TROndokuz Mayıs University · TRRwanda Meteorological Service · RWUniversity of Birmingham · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimThis article aims to study the benefits and disadvantages of stem cell therapy, especially for patients who have dementia.

methodsThe databases PubMed, Google Scholar, and the National Library of Medicine were searched for literature. All papers on Alzheimer's disease, Lewy body dementia, Parkinson's disease, stem cell therapy, and its effect on dementia treatment were considered.

resultsStem cell treatment has demonstrated promising outcomes in animal studies by positively modifying the degenerative alterations in dementia. However, it is not without drawbacks, such as ethical concerns while using embryonic stem cells and the danger of developing cancer if the cells undergo uncontrolled differentiation.

conclusionAlthough stem cell therapy has its risks, it has the potential to be a viable therapeutic option for patients with dementia if developed appropriately. Hence, more research and clinical trials are needed to establish its efficacy in this context.

Indexed as

Alzheimer DiseaseLewy Body DiseaseParkinson DiseaseAnimalsCell- and Tissue-Based TherapyAlzheimer's diseasedementiaLewy body dementiaParkinson's diseasestem cells

Identifiers

PMID35971625
PMCPMC9480940
OpenAlexW4291941743

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.